The publisher's Medical Devices sector report, “Electrophysiology Ablation Catheters - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Electrophysiology Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Electrophysiology Ablation Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies
5 Electrophysiology Ablation Catheters Companies and Product Overview
7 Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ablacon Inc
- Acotec Scientific Co Ltd
- Apama Medical Inc
- Biosense Webster Inc
- BioTex Inc
- Boston Scientific Corp
- CardioFocus Inc
- CardioNova Ltd
- CathEffects LLC
- CathRx Ltd
- Cibiem Inc
- Columbia University
- Cordis Corp
- CoreMap Inc
- CPSI Biotech
- CryoTherapeutics Gmbh
- Epicardial Technologies Inc (Inactive)
- Ethicon US LLC
- Eximo Medical Ltd
- FocusStart LLC
- Hansen Medical Inc (Inactive)
- Hyblate Medical
- Imricor Medical Systems Inc
- Interventional Imaging, Inc.
- Iowa Approach Inc.
- Maestro Heart SA
- Medlumics SL
- Medtronic Plc
- MedWaves Inc
- MicroPort Scientific Corp
- Northwestern University
- Novasentis Inc
- S4 Medical Corp
- SCR, Inc.
- Seattle Children's Hospital
- Shanghai HeartCare Medical Technology Co Ltd
- Shanghai MicroPort EP MedTech Co Ltd
- St. Jude Medical LLC
- Stereotaxis Inc
- University of Arkansas at Little Rock
- University of Michigan
- University of Rochester
- University of Texas Medical Branch at Galveston
- Vanderbilt University
- Vimecon GmbH
- Vivonics Inc
- Voyage Medical (Inactive)
- Zylox-Tonbridge Medical Technology Co Ltd
